ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019) (DEFINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00685776
Recruitment Status : Completed
First Posted : May 28, 2008
Last Update Posted : December 11, 2017
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2, 2009
  Actual Study Completion Date : November 23, 2017
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):